Evolving Evidence for Protected PCI with Impella to Treat High-Risk Complex CAD Patients

Results from the PROTECT clinical studies consistently demonstrate a reduction in MACCE at 90 days after Protected PCI with the Impella heart pump.

IMP-1131
IMP-1543